S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 130 KRW -2.41% Market Closed
Market Cap: 219.7B KRW

Wall Street
Price Targets

Price Targets Summary
Samil Pharmaceutical Co Ltd

Wall Street analysts forecast Samil Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Samil Pharmaceutical Co Ltd is 13 260 KRW with a low forecast of 13 130 KRW and a high forecast of 13 650 KRW.

Lowest
Price Target
13 130 KRW
30% Upside
Average
Price Target
13 260 KRW
31% Upside
Highest
Price Target
13 650 KRW
35% Upside
Samil Pharmaceutical Co Ltd Competitors:
Price Targets
JUBLPHARMA
Jubilant Pharmova Ltd
30% Upside
ANCR
Animalcare Group PLC
42% Upside
KLBF
Kalbe Farma Tbk PT
48% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
32% Upside
867
China Medical System Holdings Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Samil Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Samil Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 9%.

7%
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Samil Pharmaceutical Co Ltd

The compound annual growth rate of Samil Pharmaceutical Co Ltd's operating income for the next 3 years is 255%.

N/A
Past Growth
255%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Samil Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Samil Pharmaceutical Co Ltd's stock price target?
Price Target
13 260 KRW

According to Wall Street analysts, the average 1-year price target for Samil Pharmaceutical Co Ltd is 13 260 KRW with a low forecast of 13 130 KRW and a high forecast of 13 650 KRW.

What is Samil Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Samil Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 9%.

What is Samil Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
255%

The compound annual growth rate of Samil Pharmaceutical Co Ltd's operating income for the next 3 years is 255%.

Back to Top